ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Machine Learning-Driven Capillary Microfluidic Design Automation for Programmable Gradient Generation and Antimicrobial Testing.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Rapid, portable, and automated determination of minimum inhibitory concentration (MIC) is critical for antimicrobial susceptibility testing in decentralized settings. We present TCG-CMDA (Tree-Shaped Concentration Gradient generator enabled by Capillary Microfluidic Design Automation), a machine learning-guided platform for the automated design of capillary microfluidic chips that passively generate programmable concentration gradients. A key innovation of TCG-CMDA is its ability to achieve fully synchronized, capillary-driven flow of two preloaded agents, enabling precise and reproducible gradient formation without external pumps or valves. By integrating computational fluid dynamics (CFD) simulations, a neural network surrogate model, and quasi-Newton optimization, the platform customizes tree-shaped geometries to match target mixing profiles. We validate TCG-CMDA through dye flow visualization and MIC testing of Escherichia coli against gentamicin, showing high concordance with conventional antibiotic susceptibility testing. The resulting chip supports a streamlined workflow consisting of passive loading, autonomous gradient generation, and incubation (∼2 h), followed by direct endpoint assessment, making it well suited for decentralized point-of-care applications. TCG-CMDA establishes a closed-loop, simulation-guided design paradigm for capillary microfluidic systems. Although demonstrated here for MIC-oriented antimicrobial testing, the framework is generalizable and can be extended to other gradient-dependent microfluidic applications through geometry reconfiguration and fluid-specific optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.